Neoadjuvant Therapy Remodels the Pancreatic Cancer Microenvironment via Depletion of Protumorigenic Immune Cells

Sadeleştirilmiş öğe sayfası
dc.contributor.authorReyes, Carmen Mota
dc.contributor.authorTeller, Steffen
dc.contributor.authorMuckenhuber, Alexander
dc.contributor.authorKonukiewitz, Bjoern
dc.contributor.authorSafak, Okan
dc.contributor.authorWeichert, Wilko
dc.contributor.authorFriess, Helmut
dc.contributor.authorCeyhan, Gueralp O.
dc.contributor.authorDemir, Ihsan Ekin
dc.date.accessioned2025-10-16T15:22:10Z
dc.date.issued2020
dc.identifier.doi10.1158/1078-0432.CCR-19-1864
dc.identifier.otherWOS:000505668000025
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/7794
dc.publisherAMER ASSOC CANCER RESEARCH
dc.sourceCLINICAL CANCER RESEARCH
dc.titleNeoadjuvant Therapy Remodels the Pancreatic Cancer Microenvironment via Depletion of Protumorigenic Immune Cells
dc.typeArticle

Dosyalar

Koleksiyonlar

WOS